U.S. Other Utilities Stock News

NVR (NVR) stock is back in focus after first quarter 2026 results showed lower profit and revenue, weaker homebuilding margins, and a drop in settlements, with earnings missing analyst expectations and pressuring sentiment. See our latest analysis for NVR. The weaker first quarter results and earnings miss have gone hand in hand with a 23.66% 90 day share price return decline and a 16.17% fall in 1 year total shareholder return, suggesting momentum has cooled after a modest 3 year gain. If...

Commvault Systems recently reported fourth-quarter 2026 revenue of US$311.69 million and full-year revenue of US$1.18 billion, issued fiscal 2027 guidance calling for US$1.30–US$1.31 billion in total revenue, completed a major share repurchase program, and expanded its Commvault Cloud platform availability to Google Cloud Marketplace. These developments, alongside growing annual recurring revenue and upcoming presentations at Google Cloud Next 2026 and the GEOINT Symposium 2026, highlight...

Smurfit Westrock Plc recently reported past first-quarter 2026 results showing sales of US$7,712 million, broadly flat year-on-year, while net income dropped to US$65 million and earnings per share fell to US$0.12. Despite the sharp profit compression and operational challenges, the company affirmed a quarterly dividend of US$0.4523 per share and outlined mill and site closures alongside a review of its London Stock Exchange listing. We’ll now examine how the sharp drop in quarterly profit...

Matson stock moves and recent performance snapshot Matson (MATX) has caught investor attention after recent share price moves, with the stock showing mixed short term returns but gains over the past month, past 3 months, year to date and past year. See our latest analysis for Matson. Recent trading has been choppy, with a 1 day share price return of a 1.57% decline and a 7 day share price return of a 3.34% decline. However, the 30 day and year to date share price returns of 2.67% and 38.09%...

Lazard, Inc. has already reported first‑quarter 2026 results, with net income rising to US$100.92 million and diluted EPS from continuing operations at US$0.91, alongside affirming a US$0.50 per‑share quarterly dividend and continuing a buyback program. Beyond the headline figures, the quarter highlighted a contrast between strong revenue and asset management inflows and an adjusted earnings miss versus analyst expectations, raising fresh questions about cost discipline and earnings...

In April 2026, Regal Rexnord’s board declared a US$0.35 per share quarterly dividend payable on July 14, 2026, and also held its regular board meeting. The board simultaneously finalized a leadership transition plan, appointing Schneider Electric executive Aamir Paul as incoming CEO and director, signaling a shift in operational and growth priorities. Next, we’ll examine how bringing in Aamir Paul as CEO could influence Regal Rexnord’s investment narrative built around efficiency and...

Q1 earnings, guidance and BetterHelp's insurance shift Teladoc Health (TDOC) has been back in focus after Q1 2026 results and updated guidance put its BetterHelp insurance transition front and center for investors watching the virtual care stock. See our latest analysis for Teladoc Health. The stock has seen short term momentum build, with a 30 day share price return of 25.81% and a 90 day gain of 29.75%. However, the 1 year total shareholder return of 7.27% and 3 year total shareholder...

M/I Homes, Inc. reported past first-quarter 2026 results, with revenue of US$920.71 million and net income of US$67.83 million, both lower than a year earlier. The company also completed a share repurchase of 587,034 shares for US$79.65 million, reducing its share count by 2.27%, which can lift per-share metrics even as earnings soften. We’ll now examine how the weaker first-quarter earnings, alongside the ongoing buyback, affect M/I Homes’ existing investment narrative. Uncover the next big...

XCF Global, Inc. recently presented at Water Tower Research’s Circular Economy symposium and issued a Q1 2026 update outlining leadership additions, a binding offtake term sheet with BGN, and a planned June 2026 restart of its New Rise Renewables Reno facility. The company also entered a forbearance agreement with Twain and set 2027 operational targets for revenue and renewable fuel output, signaling a more defined roadmap for its Reno-based circular fuel platform. Against this backdrop,...

NASA award puts Aeluma (ALMU) quantum dot laser platform in focus A new NASA award for Aeluma (ALMU) to advance its integrated quantum dot laser platform for data communication and sensing has put the stock on the radar for investors watching AI infrastructure and defense exposure. See our latest analysis for Aeluma. Aeluma’s share price has been volatile, with a 70.83% 30 day share price return and a 44.27% 90 day share price return, while the 1 year total shareholder return sits at 107.22%,...

In April 2026, Phillips Edison & Company, Inc. raised its 2026 net income per-share guidance to US$0.79–US$0.81 and reported first-quarter revenue of US$190.74 million and net income of US$30.38 million, both higher than a year earlier. Together with Vanguard Capital Management disclosing a 5.35% ownership stake, these updates highlight growing institutional interest alongside improving profitability metrics for the grocery-anchored retail REIT. Now, we’ll consider how the upgraded full-year...

On April 28, 2026, Community Trust Bancorp’s board declared a quarterly cash dividend of US$0.53 per share, payable on July 1, 2026 to shareholders of record on June 15, 2026. The dividend decision, alongside director share awards and dividend reinvestment activity, highlights the board’s emphasis on cash returns while maintaining insider alignment. We’ll now examine how this reaffirmed quarterly dividend shapes Community Trust Bancorp’s investment narrative, particularly around income...

Why A10 Networks (ATEN) is back on investor radar A10 Networks (ATEN) just reported first quarter revenue of US$75 million and net income of US$12.03 million, ahead of the prior year, while reaffirming full year guidance that indicates earnings growth outpacing revenue growth. See our latest analysis for A10 Networks. The latest earnings beat, reiterated guidance and ongoing share buyback have landed against a strong run in the stock, with a 90 day share price return of 56.57% and a five year...

Greif, Inc. has reported past second-quarter 2026 results showing sales of US$1,072.8 million, slightly below the prior year, and net income falling to US$12.6 million from US$39.9 million, while six-month net income rose to US$187.2 million despite marginally lower sales of US$2,067.6 million. The contrast between weaker quarterly profit and much stronger six-month earnings highlights how timing of costs and benefits from its portfolio reshaping may be affecting Greif’s near-term...

On 1 May 2026, Vir Biotechnology director Vicki L. Sato sold 22,000 shares under a Rule 10b5-1 plan, while the company and Astellas Pharma completed their collaboration agreement and dosed the first patient in a Phase 1 expansion cohort for VIR-5500 in metastatic prostate cancer. This combination of insider selling and tangible progress in Vir’s oncology pipeline highlights the growing importance of VIR-5500 within its broader development portfolio. We’ll now examine how progress on VIR-5500...

Why Watsco (WSO) Is On Investors’ Radar Today Recent moves in Watsco (WSO) share price have drawn attention, with the stock showing mixed short term performance while still posting gains over the past month and past 3 months. See our latest analysis for Watsco. At a share price of $414.78, Watsco has pulled back in the very short term, with a 1 day share price return of 3.22% decline and a 7 day share price return of 9.21% decline, even though its year to date share price return of 19.42% and...

Arrowhead Pharmaceuticals (ARWR) is back in focus after Australia’s Therapeutic Goods Administration approved REDEMPLO (plozasiran) to treat adults with familial chylomicronemia syndrome, extending the drug’s reach beyond the United States, Canada, and China. See our latest analysis for Arrowhead Pharmaceuticals. Those regulatory wins appear to be reflected in the share price, with a 25.17% 1 month share price return and a 12.69% year to date share price return, alongside a 1 year total...

Event context and recent share performance Lithia Motors (LAD) has drawn fresh attention after recent share price moves, with the stock down about 15% year to date but up roughly 12% over the past month. Over the past 3 months, Lithia Motors has recorded a total return decline of about 14%, while its 1 year total return is slightly negative despite a 3 year total return above 30%. See our latest analysis for Lithia Motors. At a share price of $282.02, Lithia Motors has recently seen a 12% 1...

In April 2026, Huntington Bancshares reported first-quarter net income of US$523 million, maintained its US$0.155 quarterly common dividend, detailed a series of preferred stock dividends, and launched a new up-to-US$3.00 billion share repurchase program after completing US$250 million of an earlier buyback. The quarter highlighted how the Cadence and Veritex acquisitions drove strong revenue growth and a larger balance sheet while integration costs and higher credit provisions limited...

Daqo New Energy (DQ) just reported first quarter 2026 results that combined sharp revenue contraction, wider net losses and ongoing cash burn, while management kept a cautious tone but pointed to possible policy driven price support. See our latest analysis for Daqo New Energy. Daqo New Energy’s recent earnings and guidance arrived after a weak share price stretch, with a 90 day share price return of 14.63% and a year to date share price return of 32.74% decline, but a 1 year total...

Zymeworks (ZYME) stock is in focus after the company reported early Phase 1 data for its folate receptor alpha targeting antibody drug conjugate ZW191 at the AACR 2026 Annual Meeting. See our latest analysis for Zymeworks. At a share price of $26.78, Zymeworks has a 90 day share price return of 14.25% and a 1 year total shareholder return of 108.40%, suggesting momentum has been strengthening as data like the ZW191 Phase 1 update lands. If this kind of oncology news has your attention,...

Global markets may be dealing with inflation, shifting rate expectations, and energy volatility, but companies tackling long-term health challenges like Parkinson’s disease are still pushing ahead.

Liberty Broadband (LBRD.K) shares have been reacting to its first quarter earnings, where the company reported net income of US$203 million and earnings per share below the prior year period. See our latest analysis for Liberty Broadband. That earnings update has come alongside a sharp reset in sentiment, with a 30 day share price return of a 24.54% decline and a 1 year total shareholder return of a 55.04% loss, pointing to fading momentum rather than a short term pullback. If this kind of...

Chemed Corporation recently reported first-quarter 2026 results, with net income of US$66.3 million versus US$71.76 million a year earlier, and continued its long-running buyback by repurchasing 500,000 shares for US$197.7 million. An interesting nuance is that, despite softer earnings, Chemed has now retired about 71.73% of the shares authorized under its 2011 repurchase program, underscoring management’s ongoing commitment to returning capital. We’ll now examine how this combination of...